Entering global development phase
Year-end Report 2025
"2025 marked a pivotal year for Cereno Scientific. As we enter 2026, our priority is clear: initiate the global Phase IIb trial with CS1, maintain close regulatory interaction and execute the trial with operational excellence."
CEO
Contact